Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Nov 27, 2005 2:45pm
296 Views
Post# 9927206

RE: Why the decline in Share Price?

RE: Why the decline in Share Price?But the victims are more likely the faithful longs, not newcomers. There hasn't been any news release with content that would attract newcomers in several years. I’m not sure who you refer to when you say faithful longs, if it is the oncult, then I agree they are unknowing victims, since are blind, though it isn't clear whether that is by choice or not. For longs who have the capability for thinking for themselves and have been around long enough to know better, but continue to believe Thompson, they have no one to blame but themselves, imo. As for judging whether there have been any recent news releases that would attract newcomers, I think onc's history of submitting "news" about reovirus to publications geared to consumers (see yahoo post 30040 as well as h**p://hirebio.com/c/biotech/newsdetailx/10271.htm are suggestive they are purposely reaching out to consumers and other potentially unsophisticated investors to attract newcomers money. imo, the one on the poster sessions, combined with the MB pumping & hyping were designed to do just that – I haven’t checked out all the posts since late September, but there seems to be a lot of new aliases popping up – that doesn’t necessarily mean they are new to onc, perhaps they’ve been lurking, but I think the number of new posters is at least suggestive of new investors. Additionally, since Thompson & his MB pumpers must know that the oncult is over-invested financially & emotionally in onc so their buying power is limited and much of the rest of the long term longs have likely reduced their core holdings to much smaller amounts and likely trade the balance of their oncy shares, that leaves only the hedge fund financiers and newcomers left. Guess who wins there? jmo
Bullboard Posts